Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit.
Desai
Akshay
A
D000077545:Eplerenone; D006331:Heart Diseases / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000453:epidemiology; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D012084:Renin-Angiotensin System / Q000187:drug effects*; D018570:Risk Assessment; D012307:Risk Factors; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives*
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone